Name: J3M-MC-JZQH CN
Author: Medable, Inc.

Technical Specs

Bundle ID com.medable.lilly-jzqh.patient.cn

Version 5.4.1100

App Store Size 100.24 MB

Minimum iOS 14.0

Devices iPhone, iPad, iPod touch

Catalog release date 2025-03-26

Latest recorded version date 2025-11-20

Features & Support

Advisory 4+

Languages (57)

AF, AR, AS, BN, BG, CA, HR, CS, DA, NL, EN, ET, FI, FR, GL, KA, DE, EL, GU, HT, HE, HI, HU, IT, JA, KN, KO, LV, LT, MS, ML, MR, NB, OR, PL, PT, PA, RO, RU, SR, ST, TN, ZH, SK, SL, ES, SV, TA, TE, TH, ZH, TR, UK, UR, VI, XH, ZU

Top In App Purchases

No In App Purchases Listed

Preview

Description

A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination with Standard of Care Immunotherapy in Participants with Resected or Unresectable KRAS G12C-Mutant, Non-Small Cell Lung Cancer - SUNRAY-02. This app is specifically intended for participants in the J3M-MC-JZQH study only.

What's New

Version 5.4.1100 2025-11-20

This update includes improvements and bug fixes to enhance your experience.

Technical Analysis

Package Overview Basic metadata

Bundle ID com.medable.lilly-jzqh.patient.cn

Current Version 5.4.1100

Minimum iOS 14.0

Package Size App Store Size

Package Metadata 1 / 2 version records

Detailed binary, privacy manifest, framework, and Info.plist results have not been indexed for this package yet. The verified App Store and archive metadata above remains available.

Developer Information

Website

Known Version Records

1 version record with stored package metadata • 2 known version records

Stored metadata does not guarantee a package is currently available to download.

Details	Version / IDs	Version date	Action
Not archived	App Store ID: 876683146	Unknown	Request Version
49.23 MB	v5.4.900 App Store ID: 873218877Build: 2838314	2025-03-21 11:20:06	Get Version